These data show that the expression of fascin represents a phenotypic change in colorectal carcinomas and that fascin is associated with a poorer prognosis in colorectal cancer patients (Hashimoto et al, 2006; Puppa et al, 2007). Here, FSCN1 is linked to colorectal cancer.